Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head and Neck Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03682562
What this trial is testing

Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions

Who this might be right for
Oral CancerOral Lichen PlanusOral Leukoplakia
Cairo University 93
Testing effectiveness (Phase 2)Looking for participantsNCT06997068
What this trial is testing

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Who this might be right for
Metastatic Oral Cavity CarcinomaRecurrent Oral Cavity CarcinomaStage IVC Lip and Oral Cavity Cancer AJCC v8+15 more
Mayo Clinic 25
Not applicableStudy completedNCT00537797
What this trial is testing

Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

Who this might be right for
Thyroid Neoplasms
Washington University School of Medicine 84
Early research (Phase 1)Study completedNCT01184482
What this trial is testing

Lapatinib and Cetuximab in Patients With Solid Tumors

Who this might be right for
Colorectal CancerLung CancerHead and Neck Cancer
Georgetown University 22
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Early research (Phase 1)Active Not RecruitingNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Not applicableUnknownNCT05796960
What this trial is testing

European Multicenter Study on Surgical Management of Advanced Thyroid Cancer

Who this might be right for
Thyroid CarcinomaThyroid CancerThyroid Neoplasms+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 3,917
Testing effectiveness (Phase 2)Looking for participantsNCT06240689
What this trial is testing

A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 104
Not applicableLooking for participantsNCT06822413
What this trial is testing

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Who this might be right for
Cancer DiagnosisLiver Cancer, AdultCancer Screening+14 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 600
Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Early research (Phase 1)Study completedNCT00019435
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+4 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01727076
What this trial is testing

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Ended earlyNCT04989387
What this trial is testing

Study of INCA 0186 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSquamous Cell Carcinoma of the Head and Neck (SCCHN)Gastrointestinal (GI) Malignancies
Incyte Corporation 57
Early research (Phase 1)Study completedNCT05241834
What this trial is testing

LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

Who this might be right for
Carcinoma, Non-Small-Cell LungThyroid Neoplasms
Eli Lilly and Company 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Not applicableEnded earlyNCT02975739
What this trial is testing

Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors

Who this might be right for
RadioisotopesHead and Neck Neoplasms
UMC Utrecht 1
Testing effectiveness (Phase 2)Study completedNCT05597839
What this trial is testing

Study of DF9001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 24
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT04895709
What this trial is testing

BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Who this might be right for
Cervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more
Bristol-Myers Squibb 1,109
Next Page